ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990

In Brief: Howard Skipper Retires; Oglesby To Head SRI; John Montgomery Named Kettering-Meyer Director

December 19, 1980

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

Institute of Medicine Elects 80 New Members

October 24, 2014

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011